Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1999-08-11
Original market date: See footnote 1
1993-12-31
Product name:
RELEFACT TRH INJECTION 200MCG/ML
DIN:
01987763 Electronic product monograph is not available
Company:
HOECHST ROUSSEL CANADA INC.
2150 Boul. St-Elzear Ouest
Laval
Quebec
Canada
H7L 4A8
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
36:60.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V04CJ02 PROTIRELIN
Active ingredient group (AIG) number:See footnote5
0111428001
Active ingredient(s) | Strength |
---|---|
PROTIRELIN | 200 MCG / ML |